Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Cheap Robotics Stocks To Buy Now

by Global Market Bulletin
February 22, 2026
in Stock Market News
0
Top 10 Cheap Robotics Stocks To Buy Now

Top 10 Cheap Robotics Stocks To Buy Now

149
SHARES
324
VIEWS
Share on FacebookShare on Twitter

3. Richtech Robotics Inc. (NASDAQ:RR)

Market Cap: $583.59 M

You might also like

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

Richtech Robotics Inc. (NASDAQ:RR) closed at $2.78 on February 20, 2026, trading between $2.67 and $2.82 with volume of just over 10 million shares, below its average daily turnover, as legal headlines continued to cloud near-term sentiment around this AI-focused industrial robotics stock. With a market capitalization near $480 million and a 52-week range of $1.37 to $7.43, RR stock is currently trading well below its 50-day moving average of $3.78, reflecting the volatility triggered by a disputed Microsoft collaboration claim and multiple securities class-action notices. The legal scrutiny, including inquiries tied to the January announcement and subsequent media denials, has introduced reputational risk and short-term uncertainty, amplifying price swings and pressuring investor confidence in what was previously positioned as a high-growth artificial intelligence and robotics play.

From a financial standpoint, Richtech Robotics remains an early-stage AI and service automation company with negative earnings per share of approximately -0.13 and a trailing negative price-to-earnings ratio, underscoring that profitability has yet to materialize. Revenue per share remains minimal, driving a high price-to-sales multiple that reflects future growth expectations rather than current operating scale. However, the balance sheet shows relative strength, with cash per share around $1.66, book value per share near $1.72, low leverage, and a current ratio well above industry norms, suggesting a cash-heavy structure capable of supporting ongoing product development and commercialization efforts. This combination of strong liquidity and weak operating margins places RR stock squarely in the speculative growth category within the broader AI sector and industrial automation landscape.

Technically, momentum indicators have pointed to an oversold bias, with the stock trading near lower Bollinger Band levels and below key trend averages, which may invite mean reversion if legal overhangs stabilize. Model-based projections from AI-driven analytics platforms have suggested potential upside toward mid- to high-single-digit price targets over a one-year horizon, though such forecasts remain conditional on execution, litigation resolution, and sustained adoption of Richtech Robotics’ service automation and embodied AI solutions. The broader AI sector context also matters, as investor appetite has favored scalable software platforms over hardware-heavy robotics names, leaving hybrid models like Richtech navigating both robotics adoption cycles and artificial intelligence sentiment shifts.

Ultimately, the investment case for Richtech Robotics Inc. (NASDAQ:RR) hinges on whether the company can convert enterprise interest in AI-powered robotics into durable revenue growth while clearing legal uncertainties that currently weigh on valuation. At $2.78, RR stock represents a high-risk, high-reward artificial intelligence and robotics equity where upside potential is tied to validated partnerships, improved financial performance, and restored market credibility, balanced against ongoing litigation risk, dilution concerns, and the execution challenges inherent in scaling an emerging industrial AI platform.

Click next to see the following stock...

Page 4 of 6
Prev1...3456Next
Tags: Duos Technologies Group Inc. (NASDAQ:DUOT)Ekso Bionics Holdings Inc. (NASDAQ:EKSO)Knightscope Inc. (NASDAQ:KSCP)Microbot Medical Inc. (NASDAQ:MBOT)Nauticus Robotics Inc. (NASDAQ:KITT)Palladyne AI Corp. (NASDAQ:PDYN)Primech Holdings Ltd. (NASDAQ:PMEC)Rapid Micro Biosystems Inc. (NASDAQ:RPID)Richtech Robotics Inc. (NASDAQ:RR)Serve Robotics Inc. (NASDAQ:SERV)Top 10 Cheap Robotics Stocks To Buy Now
Share60Tweet37

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
June 6, 2026
0
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

by Global Market Bulletin
June 6, 2026
0
Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy
  • Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?
  • Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?